SEQENS Competitors and Similar CompaniesClear all

SEQENS's competitors and similar companies include Sartorius Stedim Biotech, Dottikon, Cytiva and Parexel International.
SEQENS
SEQENS
SEQENS (previously known as Novacap) is a company specializing in pharmaceutical synthesis and specialty ingredients.
Sartorius Stedim Biotech
Sartorius Stedim Biotech
Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.
Dottikon
Dottikon
Dottikon ES Holding is a company that manufactures active pharmaceutical ingredients, intermediates, and performance chemicals.
Cytiva
Cytiva
Cytiva (also known as Global Life Sciences Solutions USA, formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics.
Parexel International
Parexel International
Parexel International (MA) is a clinical research organization.
Founding Date
Founding Date
2003
Founding Date
2007
Founding Date
1913
Founding Date
1968
Founding Date
1982
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Écully, FR HQ
Saint Jean Sur Richelieu, CA
Taizhou Shi, CN
Zhenjiang, CN
Turku, FI
Bourgoin Jallieu, FR
see more
Locations
Aubagne, FR HQ
Jaipur, IN
Bohemia, US
Locations
Dottikon, CH HQ
Locations
Marlborough, US HQ
Parramatta, AU
Wagram, AT
Wien, AT
Hangzhou, CN
Shanghai, CN
see more
Locations
Newton, US HQ
Olivos, AR
Vicente López, AR
Brisbane, AU
Macquarie Park, AU
Wavre, BE
Sao Paulo, BR
see more
Employees
Employees
3,300
Employees
10,082
Employees
726
Employees
9,3991% increase
Employees
20,867

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€2.8b (FY, 2024)
Revenue (est.)
CHF326.3m (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
€1.3b (FY, 2024)
Cost of goods
CHF109.1m (FY, 2024)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
€1.5b (FY, 2024)
Gross profit
CHF219.1m (FY, 2024)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
€178.5m (FY, 2024)
Net income
CHF80.6m (FY, 2024)
Net income
N/A
Net income
N/A

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
41 (May, 2023)
Countries
52 (FY, 2017)
For sources of this data, please see the company profile

View Company Profiles

Sartorius Stedim Biotech
HQ
Aubagne, FR
Employees
10,082

Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.

View company
Dottikon
HQ
Dottikon, CH
Employees
726

Dottikon ES Holding is a company that manufactures active pharmaceutical ingredients, intermediates, and performance chemicals.

View company
Cytiva
HQ
Marlborough, US

Cytiva (also known as Global Life Sciences Solutions USA, formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics.

View company
Parexel International
HQ
Newton, US
Employees
20,867

Parexel International (MA) is a clinical research organization.

View company